Oncology Kit Portfolio (e.g., QuantideX)

About Asuragen

Asuragen is a private, commercial-stage molecular diagnostics company that has been delivering standardized testing kits to clinical and research laboratories since its founding in 2006. The company's core business revolves around simplifying complex molecular tests, particularly in genetics and oncology, through ready-to-use kits and reagents. It operates in the growing in-vitro diagnostics (IVD) market, serving labs that require robust, reproducible assays. Asuragen's strategy is built on a portfolio of analytically validated products that aim to improve testing accessibility and efficiency.

Therapeutic Areas